Get our lovely INSIGHT 2019 conference news


Email address
First Name
Last Name
Interested in InSight 2019
Cart
<We_can_help/>

What are you looking for?

<Good_things_happen/> Welcome to Conference

Research with Psychedelics: Translating Lab Findings into Therapeutic Applications

Decades ago MDMA and LSD entered the therapeutic setting and already then showed their therapeutic potential in the treatment of psychiatric disorders. Since thousands of years another psychedelic, ayahuasca, is being used by tribes in the western Amazonia for healing and divination, and in recent years its use has expanded worldwide.
Research into the therapeutic potential of these substances has re-emerged and (preliminary) findings are promising. Depression and anxiety disorders are amongst the disorders of focus. Since both are characterized by cognitive rigidity and disturbed empathy our aim was to investigate whether psychedelics can change and improve this behavior acutely and with a longer duration. To that end, we conducted a series of studies assessing the acute and longer-term effects of ayahuasca and psilocybin on creative thinking and empathy in both a naturalistic and an experimental setting.
Findings from these studies will be presented and implications for future therapeutic applications discussed.

Speaker

Date

September 6th 2019

Time

9:30 - 10:00

Location

Auditorium
tickets
Kim Kuypers
Prof. Dr.

Kim Kuypers

Maastricht University, Fac. of Psychology and Neuroscience, Dept. of Neuropsychology and Psychopharmacology, Assistant Professor more about the speaker

Related Events

Integration Psychotherapy

This talk will focus on Psychedelic Integration in a clinical setting...

more details

How Altered States of Consciousness Have a Healing Potential in Psychiatric Illness

Time consciousness and self consciousness are intrinsically related. Subjective time is generated through the sense of self as it is anchored in bodily feelings...

more details

Current Research on LSD in Healthy Subjects and Patients

Lysergic acid diethylamide (LSD) is used in Switzerland in the treatment of patients both in the context of compassionate use and in clinical studies including patients with anxiety associated with life-threatening diseases...

more details

Psychedelic Medicines: A Paradigm Shift from Pharmacological Substitution Towards Transformation-Based Psychiatry

While psychoactive drugs such as ketamine and psilocybin have been researched extensively in the past decades, scientific interest in ayahuasca has just started to grow, due to its potential therapeutic benefits....

more details

Conference tickets

With your ticket you will have access to the whole conference - with keynotes, panels, round tables, posters and daylight social events. We will ask for a small extra fee for the Friday evening social program. The pre-conference workshops have to be booked separately and each workshop needs an individual ticket. By clicking on "Book now" below you also have the option to buy your workshop tickets.

*Reduced fees apply to students, cooperation partners as well as unemployed and retired individuals who have a monthly net income below 840,- €. Proof of status will be required.

Early bird

until 14 April 2019

  • Standard €170
  • Reduced €80*
  • MIND members Standard €100
  • MIND members Reduced €50

Regular

after 14 April 2019

  • Standard €250
  • Reduced €150*
  • MIND members Standard €180
  • MIND members Reduced €90

Philanthropist

 

  • Donate €600 or more
  • Invite a friend/colleague to be your VIP guest at the event

Get our lovely INSIGHT 2019 conference news


Email address
First Name
Last Name